Metabolomics Analysis Reveals Altered Metabolic Pathways and Response to Doxorubicin in Drug-Resistant Triple-Negative Breast Cancer Cells

This study aimed to investigate metabolic changes following the acquisition of resistance to doxorubicin in the triple-negative breast cancer (TNBC) cell line MDA-MB-231. Two drug-resistant cell lines, DOX-RES-50 and DOX-RES-100, were generated by treating MDA-MB-231 cells with doxorubicin for 24 h...

Descripción completa

Detalles Bibliográficos
Autores principales: Rushing, Blake R., Molina, Sabrina, Sumner, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383792/
https://www.ncbi.nlm.nih.gov/pubmed/37512572
http://dx.doi.org/10.3390/metabo13070865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383792/
https://www.ncbi.nlm.nih.gov/pubmed/37512572
http://dx.doi.org/10.3390/metabo13070865

Ejemplares similares